Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 123
Filter
1.
Orbit ; 39(6): 403-407, 2020 Dec.
Article in English | MEDLINE | ID: mdl-31858864

ABSTRACT

PURPOSE: Assessment of lacrimal resistance in patients with patent lacrimal systems is important in determining whether dacryocystorhinostomy (DCR) surgery is appropriate. Current techniques, including lacrimal syringing and dacryoscintigraphy (DSG), can be unreliable. We compare the results of a manometric tear duct test (mTDT) irrigation technique with DSG in these patients. METHODS: All symptomatic patients in a specialist lacrimal clinic had full work-up apart from syringing. Lacrimal resistance was assessed using mTDT which applies a fixed head of fluid pressure via a cannula sealed to punctum. Conventional syringing was also performed in cases with abnormal mTDT. Symptomatic patients with delayed tear clearance, no external cause for watering and patent lacrimal systems had DSG. MTDT and DSG results were compared, including in asymptomatic fellow eyes. RESULTS: 105 tear ducts were examined, 85 symptomatic. Symptomatic eyes had a significantly higher mean mTDT resistance (p = .0003) and more had abnormal mTDT (52%) compared to asymptomatic eyes (10%). Although mean tear duct resistance was higher in those with nasolacrimal duct stenosis (NLDS) than freely patent (FP) on syringing (8.5 vs 10.8 dpm), this was not significant (p = .6). High proportions of both FP and NLDS groups had no flow at all on mTDT (60% and 53%, respectively). DSG showed no significant difference in the symptomatic versus asymptomatic eyes (p = .36), nor between those with a normal or abnormal mTDT (p = .25), nor between FP and NLDS groups (p = .25). CONCLUSIONS: In contrast to DSG, the mTDT provides valuable, objective information on lacrimal resistance that can guide a decision to DCR surgery.


Subject(s)
Lacrimal Duct Obstruction/diagnostic imaging , Nasolacrimal Duct/diagnostic imaging , Radionuclide Imaging/methods , Therapeutic Irrigation/methods , Adult , Aged , Aged, 80 and over , Dacryocystorhinostomy , Female , Humans , Male , Middle Aged , Radiopharmaceuticals/administration & dosage , Retrospective Studies , Sodium Pertechnetate Tc 99m/administration & dosage
2.
J Vasc Interv Radiol ; 30(11): 1725-1732.e7, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31279683

ABSTRACT

PURPOSE: To investigate the correlation of computed tomography (CT) angiography and 99mTechnetium-labeled red blood cell (RBC) scintigraphy to catheter angiography (CA) in the management of lower gastrointestinal bleeding (LGIB) while considering potential nephrotoxic effects of iodinated contrast. MATERIALS AND METHODS: From November 2012 to August 2017, 223 CAs performed for LGIB, including massive, ongoing, and obscure bleeding, were retrospectively identified in patients with pre-procedural CT angiography or RBC scintigraphy. Positive correlations and sensitivities were calculated for CT angiography and RBC scintigraphy using CA results as reference. Correlations were then compared while considering certain clinical presentations of LGIB. Contrast dose was compared with maximum creatinine recorded 48-72 hours after. RESULTS: Thirty-eight patients underwent CT angiography; 173 patients underwent RBC scintigraphy; and 12 patients completed both studies. CT angiography had a positive correlation of 67.7% (95% confidence interval [CI]: 57.0, 76.7) and sensitivity of 85.2% (95% CI: 66.3, 95.8), whereas RBC scintigraphy had a positive correlation of 29.3% (95% CI: 27.7, 31.0) and sensitivity of 94.4% (95% CI: 84.6, 98.8). CT angiography had higher positive correlation across all clinical presentations. No dose-toxicity relationship was observed between contrast and renal function (R2: 0.008), nor was there a difference in incidence of contrast-induced nephropathy between CT angiography and RBC scintigraphy (P = .30). CONCLUSIONS: CT angiography has greater positive correlation to CA than RBC scintigraphy for assessing LGIB in active stable as well as hemodynamically unstable LGIB. As such, greater adoption of CT angiography may reduce the number of nontherapeutic CAs performed. Additional contrast associated with CT angiography does not result in increased nephrotoxicity.


Subject(s)
Computed Tomography Angiography , Erythrocytes , Gastrointestinal Hemorrhage/diagnostic imaging , Radionuclide Imaging/methods , Radiopharmaceuticals/administration & dosage , Sodium Pertechnetate Tc 99m/administration & dosage , Adult , Aged , Aged, 80 and over , Contrast Media/administration & dosage , Female , Gastrointestinal Hemorrhage/etiology , Gastrointestinal Hemorrhage/physiopathology , Hemodynamics , Humans , Male , Middle Aged , Predictive Value of Tests , Radiopharmaceuticals/blood , Reproducibility of Results , Retrospective Studies , Risk Factors , Sodium Pertechnetate Tc 99m/blood , Young Adult
3.
Clin Exp Ophthalmol ; 47(6): 713-717, 2019 08.
Article in English | MEDLINE | ID: mdl-30866143

ABSTRACT

IMPORTANCE: This study assesses the interobserver agreement on dacryocystography (DCG) and dacryoscintigraphy (DSG) findings. BACKGROUND: There are no standard grading criteria to guide the interpretation of conventional DCG and DSG findings and therefore there may be a degree of subjectivity. This study evaluates the level of interobserver agreement in the interpretation of DCG and DSG findings. DESIGN: A retrospective observational study at the Royal Adelaide Hospital. PARTICIPANTS: A total of 165 patients who presented with epiphora with 276 DCGs and 290 DSGs performed were included in this study. METHODS: DCG and DSG images were obtained, anonymized, randomized and interpreted by three independent oculoplastic surgeons. Standard grading criteria were set for both DCG and DSG images. Data from all observers were analysed for interobserver agreement using Kappa (κ) statistics, generated using a variation of Cohen's kappa for multiple observers. MAIN OUTCOME MEASURES: Level of interobserver agreement (κ values) in the grading of DCG and DSG findings. RESULTS: There was an overall moderate interobserver agreement for DCG findings (κ = 0.55), with the highest agreement on interpreting canalicular obstruction (κ = 0.80), followed by proximal nasolacrimal duct obstruction (κ = 0.67) and normal patency (κ = 0.63). There was an overall fair interobserver agreement for DSG findings (κ = 0.36), with the best being moderate agreement (κ = 0.42-0.50) for interpreting pre-sac delay and post-sac proximal delay. CONCLUSIONS AND RELEVANCE: DCG offers good reliability in interpreting patent and obstructed systems. On the other hand, DSG has poor agreement and highlights some of the limitations in the ability to guide epiphora management.


Subject(s)
Angiography, Digital Subtraction/standards , Lacrimal Apparatus Diseases/diagnostic imaging , Nasolacrimal Duct/diagnostic imaging , Radionuclide Imaging/standards , Adult , Aged , Aged, 80 and over , Contrast Media/administration & dosage , Data Interpretation, Statistical , Female , Humans , Iohexol/administration & dosage , Iohexol/analogs & derivatives , Male , Middle Aged , Observer Variation , Predictive Value of Tests , Radiopharmaceuticals/administration & dosage , Reproducibility of Results , Retrospective Studies , Sensitivity and Specificity , Sodium Pertechnetate Tc 99m/administration & dosage
4.
Acta Pol Pharm ; 71(2): 245-8, 2014.
Article in English | MEDLINE | ID: mdl-25272643

ABSTRACT

Our aim was to prepare cheap blood pool imaging kits by simplified method to overcome the burden on purchase department of MINAR, Nishtar Hospital, Multan, Pakistan. Secondarily, prompt supply of kits should save the time of patient during transportation. A total of 24 subjects selected for this study were equally divided into two groups. Mixture of stannous chloride and sodium pyrophosphate solution at pH 7 was injected to these subjects. Various concentrations (ranging from 200 to 800 microg) of stannous chloride dihydrate were injected to group one, followed by intravenous administration of technetium-99m (99mTc) pertechnetate at 30 min interval in 12 subjects. Labeling percentage of each sample was calculated afterwards followed by imaging under gamma camera. Each parameter was tested on three different patients and average of these three was calculated. In second set of experiments done on group two the same procedure was repeated in another 12 subjects, while keeping the concentration of Sn PYP constant at 400 microg. In this case, 99mTc was administered at different time intervals in different subjects ranging from 15 to 120 min (15, 30, 60 and 120 min) followed by calculation of labeling percentage and imaging under gamma camera. In group one, average percentage values of binding of red blood cells with 99mTc were 23.24, 84.88, 83.78 and 60.33% for concentrations of 200, 400, 600 and 800 microg, respectively. In group two, average percentage binging values of 22.26, 84.36. 55.54 and 28.67% were calculated at time intervals of 15, 30, 60 and 120 min, respectively. It is concluded from the results that the best blood pool imaging under gamma camera was observed for the concentration of 400 microg and the time interval of 30 min. The maximum percentage binding of red blood cells with 99mTc was calculated at concentration of 400 microg after 30 min interval that also correlated with imaging results.


Subject(s)
Erythrocytes/diagnostic imaging , Gated Blood-Pool Imaging/methods , Radiopharmaceuticals , Sodium Pertechnetate Tc 99m , Adult , Female , Humans , Male , Middle Aged , Pakistan , Prospective Studies , Radiopharmaceuticals/administration & dosage , Sodium Pertechnetate Tc 99m/administration & dosage , Time Factors , Tin Compounds/chemistry , Young Adult
5.
Clin Nucl Med ; 49(10): e530-e531, 2024 Oct 01.
Article in English | MEDLINE | ID: mdl-39223734

ABSTRACT

ABSTRACT: Thoracoabdominal duplication cysts are a congenital malformation of the posterior primitive foregut with synchronous thoracic and abdominal duplication cysts being found in up to 15% of cases. The presentation of duplication cysts depends on their location, size, and other factors, like the presence of ectopic functioning gastric mucosa, which is reported in 20%-30% of duplication cysts. 99mTc-pertechnetate scintigraphy along with SPECT/CT helps in the preoperative localization of ectopic functioning gastric mucosa in these duplication cysts. We report the scintigraphic and SPECT/CT findings of one such case, which helped in the final diagnosis and management of the patient.


Subject(s)
Gastric Mucosa , Single Photon Emission Computed Tomography Computed Tomography , Humans , Abdomen/diagnostic imaging , Choristoma/diagnostic imaging , Cysts/diagnostic imaging , Sodium Pertechnetate Tc 99m/administration & dosage
6.
Ann Pharm Fr ; 69(3): 182-91, 2011 May.
Article in French | MEDLINE | ID: mdl-21570543

ABSTRACT

INTRODUCTION: The exposure of workers to antineoplastic agents is potentially dangerous in the long term because of the teratogenic, carcinogenic and mutagenic hazardous of these products. These risks could be reduced by individual and collective shield measures. It's recommended to use transfer devices in a closed system for preparation of chemotherapy. METHOD: The aim of the survey is to analyse for five devices (four devices in a closed system transfer and a needle equipped with an air intake), the following criteria: transfer performance of a solution of a vial to another one, no leakage of the device and practicality in the use. A method implementing a radioactive solution of sodium pertechnetate [(99m)Tc] is used. RESULTS: Teva(®) and Cardinal(®) devices seem to be more efficient according to the ability to transfer one solution from a vial to another one with a low dead volume and low-level contamination in the around of the manipulation area. The Hospira(®) device appears an intermediate solution, while the Phaseal(®) device may be irrelevant for the transfer of a solution. DISCUSSION-CONCLUSION: Our study could attest that the methodology is simple to implement and cheap to compare devices on multiple selection criteria. This evaluation method is interesting because it allows a classification according to several criteria weighted according to the type of intended use. In addition to economic issues and protection of the worker, the use of such devices should be extended to other areas as the preparation of chemotherapy such as preparation of radiopharmaceuticals drugs.


Subject(s)
Occupational Exposure/prevention & control , Sodium Pertechnetate Tc 99m/administration & dosage , Sodium Pertechnetate Tc 99m/adverse effects , Drug Compounding , Drug Therapy/instrumentation , Humans , Needles , Sodium Pertechnetate Tc 99m/analysis , Solutions
7.
Sci Rep ; 11(1): 7842, 2021 04 09.
Article in English | MEDLINE | ID: mdl-33837284

ABSTRACT

Quantitative single-photon emission computed tomography/computed tomography (SPECT/CT) using Tc-99m pertechnetate aids in evaluating salivary gland function. However, gland segmentation and quantitation of gland uptake is challenging. We develop a salivary gland SPECT/CT with automated segmentation using a deep convolutional neural network (CNN). The protocol comprises SPECT/CT at 20 min, sialagogue stimulation, and SPECT at 40 min post-injection of Tc-99m pertechnetate (555 MBq). The 40-min SPECT was reconstructed using the 20-min CT after misregistration correction. Manual salivary gland segmentation for %injected dose (%ID) by human experts proved highly reproducible, but took 15 min per scan. An automatic salivary segmentation method was developed using a modified 3D U-Net for end-to-end learning from the human experts (n = 333). The automatic segmentation performed comparably with human experts in voxel-wise comparison (mean Dice similarity coefficient of 0.81 for parotid and 0.79 for submandibular, respectively) and gland %ID correlation (R2 = 0.93 parotid, R2 = 0.95 submandibular) with an operating time less than 1 min. The algorithm generated results that were comparable to the reference data. In conclusion, with the aid of a CNN, we developed a quantitative salivary gland SPECT/CT protocol feasible for clinical applications. The method saves analysis time and manual effort while reducing patients' radiation exposure.


Subject(s)
Deep Learning , Neural Networks, Computer , Parotid Gland/diagnostic imaging , Salivary Gland Calculi/diagnostic imaging , Salivary Gland Neoplasms/diagnostic imaging , Single Photon Emission Computed Tomography Computed Tomography/methods , Thyroid Neoplasms/diagnostic imaging , Adult , Aged , Feasibility Studies , Female , Humans , Image Processing, Computer-Assisted/methods , Male , Middle Aged , Radiopharmaceuticals/administration & dosage , Sodium Pertechnetate Tc 99m/administration & dosage
8.
Cancer Gene Ther ; 27(3-4): 179-188, 2020 04.
Article in English | MEDLINE | ID: mdl-30674994

ABSTRACT

Noninvasive bioluminescence imaging (BLI) of luciferase-expressing tumor cells has advanced pre-clinical evaluation of cancer therapies. Yet despite its successes, BLI is limited by poor spatial resolution and signal penetration, making it unusable for deep tissue or large animal imaging and preventing precise anatomical localization or signal quantification. To refine pre-clinical BLI methods and circumvent these limitations, we compared and ultimately combined BLI with tomographic, quantitative imaging of the sodium iodide symporter (NIS). To this end, we generated tumor cell lines expressing luciferase, NIS, or both reporters, and established tumor models in mice. BLI provided sensitive early detection of tumors and relatively easy monitoring of disease progression. However, spatial resolution was poor, and as the tumors grew, deep thoracic tumor signals were massked by overwhelming surface signals from superficial tumors. In contrast, NIS-expressing tumors were readily distinguished and precisely localized at all tissue depths by positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging. Furthermore, radiotracer uptake for each tumor could be quantitated noninvasively. Ultimately, combining BLI and NIS imaging represented a significant enhancement over traditional BLI, providing more information about tumor size and location. This combined imaging approach should facilitate comprehensive evaluation of tumor responses to given therapies.


Subject(s)
Luciferases, Firefly/genetics , Molecular Imaging/methods , Neoplasms/diagnostic imaging , Symporters/genetics , Animals , Benzothiazoles/administration & dosage , Benzothiazoles/chemistry , Benzothiazoles/metabolism , Cell Line, Tumor , Female , Genes, Reporter/genetics , Humans , Luciferases, Firefly/metabolism , Luminescent Measurements/methods , Mice , Neoplasms/pathology , Neoplasms/therapy , Positron-Emission Tomography/methods , Radiopharmaceuticals/administration & dosage , Radiopharmaceuticals/pharmacokinetics , Sodium Pertechnetate Tc 99m/administration & dosage , Sodium Pertechnetate Tc 99m/pharmacokinetics , Symporters/metabolism , Tomography, Emission-Computed, Single-Photon/methods , Xenograft Model Antitumor Assays
9.
Nucl Med Commun ; 40(10): 995-1000, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31365496

ABSTRACT

OBJECTIVE: Our purpose was to establish a simple and feasible method for monitoring and controlling the Tc-Technegas inhaled to improve the success ratio of imaging and ensure the imaging quality. MATERIALS AND METHODS: The relationship between the success ratio and the pulmonary ventilation counting rate (VCR) of 113 cases, the activity of perfusion imaging agents injected and the pulmonary perfusion counting rate (PCR) of another 114 cases were analysed retrospectively. And combined with the relationship between the surface radioactivity monitoring value and the SPECT probe counting rate of a pulmonary model, the effective range of the VCR and the surface radioactivity monitoring value were determined. Two hundred fifty cases with Tc-Technegas inhaled monitored and controlled were used to verify the reliability and practicability of this method. RESULTS: The VCR of the ventilation/perfusion imaging with deep venous thrombosis imaging and the ventilation/perfusion imaging without deep venous thrombosis imaging was in 1.0-3.0 kct/s and 1.0-2.0 kct/s when the monitoring values of handheld radiation monitor was within the range of 60-170 µSv/h and 60-110 µSv/h, respectively. The success ratio of the V/Q-Only increased from 48.9% (43/88) of the control group to 80.8% (122/151) of the experimental group. The VCR in the two groups was examined by the non-parametric Mann-Whitney U test (P < 0.001), which indicated that there was a significant difference between the experimental group and the control group. CONCLUSION: The external monitoring method established in this study was of great significance in improving the success ratio of 1-day pulmonary ventilation/perfusion imaging and ensuring the image quality.


Subject(s)
Inhalation , Perfusion Imaging/adverse effects , Pulmonary Ventilation , Sodium Pertechnetate Tc 99m/administration & dosage , Sodium Pertechnetate Tc 99m/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies , Time Factors , Tomography, Emission-Computed, Single-Photon/adverse effects , Young Adult
10.
Cont Lens Anterior Eye ; 42(4): 359-365, 2019 08.
Article in English | MEDLINE | ID: mdl-31103453

ABSTRACT

PURPOSE: To measure tear clearance values in patients with meibomian gland dysfunction (MGD) with a dynamic nuclear medicine method, namely, dacryoscintigraphy (DSCI). METHODS: Twenty-four MGD patients and 24 healthy volunteers were examined. During DSCI one drop of a solution with 100 MBq/mL99mTc sodium pertechnetate was instilled with a micropipette into the lacrimal lake of both eyes. Measurements were performed according to a dynamic data acquisition protocol, which resulted in summed DSCI images. Data were also evaluated separately in special regions of interest (ROI), and consecutive time activity curves were created. Tear clearance (T½) values were calculated based on the activity curves. In addition, tear osmolarity measurements, tear breakup time (tBUT), and Schirmer I (STI) tests were performed prior to DSCI examination. RESULTS: The T½ values were 29.91 ± 11.61 min in MGD patients and 6.26 ± 1.5 min in healthy controls. Tear osmolarity parameters were 308 ± 9.41 mOsm/L and 288.9 ± 6.4 mOsm/L, tBUT values were 5.54 ± 2.73 s and 11.4 ± 2.7 s, while the STI test values were 6.17 ± 2.78 mm and 13.58 ± 3.8 mm, respectively. The differences were significant (p < 0.01) in all cases. CONCLUSIONS: Although the MGD patients' lacrimal drainage systems were patent their tear clearance values were significantly higher than those of healthy volunteers, which may be caused by decreased drainage of tears from the eyes towards the nasal cavity. The understanding of new features regarding the altered physico-chemical characteristics of MGD tears has been augmented by the results of this study.


Subject(s)
Lacrimal Duct Obstruction/metabolism , Meibomian Gland Dysfunction/metabolism , Tears/metabolism , Adult , Aged , Aged, 80 and over , Female , Healthy Volunteers , Humans , Lacrimal Apparatus , Lacrimal Duct Obstruction/diagnostic imaging , Male , Meibomian Gland Dysfunction/diagnostic imaging , Middle Aged , Osmolar Concentration , Radiopharmaceuticals/administration & dosage , Sodium Pertechnetate Tc 99m/administration & dosage , Tears/chemistry , Tomography, Emission-Computed/methods
11.
Biomed Res Int ; 2019: 7589853, 2019.
Article in English | MEDLINE | ID: mdl-30834273

ABSTRACT

The clinical applications of the quantitative single photon emission computed tomography (SPECT)/computed tomography (CT) are being expanded to a variety of fields of nuclear medicine. However, clinical application of quantitative SPECT/CT for the evaluation of Graves' disease (GD) still needs further investigation. Our aim was to investigate the feasibility of standard uptake value (SUV) of the thyroid for the clinical diagnosis and evaluation of GD. In this prospective multicenter study, 116 patients diagnosed with GD (Graves group) and 74 healthy volunteers (control group) were enrolled from 8 different hospitals. All patients underwent technetium pertechnetate (99mTcO4 -) SPECT/CT imaging with Q.Metrix quantitative software and 24-hour thyroid radioactive iodine uptake (24h-RAIU) test. The SUVmax and SUVmean in Graves group were significantly higher than those of control group (P<0.01). Cut-off values of SUVmax and SUVmean to predict GD were 231.425 and 116.66 by ROC curves, respectively. The SUVmax and SUVmean in Graves patients were significantly related to serum thyroxine level with correlation coefficient of 0.493 and 0.512 for FT3 and 0.449 and 0.464 for FT4, respectively (all P<0.01). Additionally, the SUVmax and SUVmean in GD positively correlated with 24h-RAIU with a coefficient of 0.832 and 0.830, respectively (P<0.01). The volumes determined by Q.Metrix (35.65 ± 20.56ml) of 72 subjects also positively correlated with that from ultrasound (36.67 ± 21.00ml) with a coefficient of 0.927 (P<0.01). SUV measurements derived from thyroid SPECT/CT may be useful for the clinical diagnosis and evaluation of GD.


Subject(s)
Graves Disease/diagnosis , Iodine Radioisotopes/administration & dosage , Sodium Pertechnetate Tc 99m/administration & dosage , Thyroid Gland/metabolism , Adult , Female , Graves Disease/blood , Graves Disease/diagnostic imaging , Graves Disease/pathology , Healthy Volunteers , Humans , Iodine Radioisotopes/metabolism , Male , Middle Aged , ROC Curve , Single Photon Emission Computed Tomography Computed Tomography , Thyroid Function Tests , Thyroid Gland/radiation effects , Thyroxine/blood , Tomography, X-Ray Computed
12.
Endocrinol Metab (Seoul) ; 34(1): 63-69, 2019 03.
Article in English | MEDLINE | ID: mdl-30784242

ABSTRACT

BACKGROUND: Postoperative routine radioiodine (RAI) treatment is currently debated for patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low ¹³¹I activity (i.e., 1 to 2 GBq) is recommended with the aim to ablate thyroid remnant and facilitate subsequent follow-up by thyroglobulin measurement. The purpose of this study was to evaluate the relationship between postsurgical technetium-99m (99mTc)-pertechnetate scintigraphy and the rate of successful remnant ablation after low activity radioiodine ablation in patients with DTC. METHODS: Enrolled were 193 patients with low risk DTC who underwent total thyroidectomy and RAI ablation with a fixed 1.1 GBq activity of ¹³¹I. 99mTc-pertechnetate scans were done and thyrotropin stimulated thyroglobulin (sTg) levels measured just before ablation. Ablation effectiveness was assessed 6 to 12 months later by sTg measurement, neck ultrasound and diagnostic whole body scan. RESULTS: A negative 99mTc-perthecnetate scans was the best predictor of successful ablation (P<0.001) followed by preablative sTg levels <0.8 ng/mL (P=0.008) and 99mTc-pertechnetate uptake rate values <0.9% (P=0.065). Neither sex nor age of the patient at the time of ablation or tumor histology and size showed a significant association with the rate of successful ablation. CONCLUSION: The 99mTc-pertechnetate scintigraphy is a simple and feasible tool to predict effectiveness of low activity ¹³¹I thyroid to ablate thyroid remnants in patients with DTC.


Subject(s)
Radionuclide Imaging/methods , Sodium Pertechnetate Tc 99m/metabolism , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/surgery , Adult , Female , Humans , Iodine Radioisotopes/administration & dosage , Iodine Radioisotopes/therapeutic use , Male , Middle Aged , Neoplasm Staging/methods , Postoperative Period , Sodium Pertechnetate Tc 99m/administration & dosage , Thyroglobulin/blood , Thyroglobulin/drug effects , Thyroid Neoplasms/radiotherapy , Thyroidectomy/methods , Thyrotropin/metabolism , Thyrotropin/pharmacology , Whole Body Imaging/methods
13.
Int J Cardiovasc Imaging ; 35(11): 2085-2093, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31197526

ABSTRACT

Little is known about the comparison of multiple-gated acquisition (MUGA) scanning with cardiovascular magnetic resonance (CMR) for serial monitoring of HER2+ breast cancer patients receiving trastuzumab. The association of cardiac biomarkers with CMR left ventricular (LV) function and volume is also not well studied. Our objectives were to compare CMR and MUGA for left ventricular ejection fraction (LVEF) assessment, and to examine the association between changes in brain natriuretic peptide (NT-BNP) and troponin-I and changes in CMR LV function and volume. This prospective longitudinal two-centre cohort study recruited HER2+ breast cancer patients between January 2010 and December 2013. MUGA, CMR, NT-BNP and troponin-I were performed at baseline, 6, 12, and 18 months after trastuzumab initiation. In total, 41 patients (age 51.7 ± 10.8 years) were enrolled. LVEF comparison between MUGA and CMR demonstrated weak agreement (Lin's correlation coefficient r = 0.46, baseline; r = 0.29, 6 months; r = 0.42, 12 months; r = 0.39, 18 months; all p < 0.05). Bland-Altman plots demonstrated wide LVEF agreement limits (pooled agreement limits 3.0 ± 6.2). Both modalities demonstrated significant LVEF decline at 6 and 12 months from baseline, concomitant with increased LV volumes on CMR. Changes in NT-BNP correlated with changes in LV diastolic volume at 12 and 18 months (p < 0.05), and LV systolic volume at 18 months (p < 0.05). Changes in troponin-I did not correlate with changes in LV function or volume at any timepoint. In conclusion, CMR and MUGA LVEF are not interchangeable, warranting selection and utility of one modality for serial monitoring. CMR is useful due to less radiation exposure and accuracy of LV volume measurements. Changes in NT-BNP correlated with changes in LV volumes.


Subject(s)
Antineoplastic Agents, Immunological/adverse effects , Breast Neoplasms/drug therapy , Magnetic Resonance Imaging , Radiopharmaceuticals/administration & dosage , Sodium Pertechnetate Tc 99m/administration & dosage , Stroke Volume/drug effects , Tomography, Emission-Computed , Trastuzumab/adverse effects , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Function, Left/drug effects , Adult , Biomarkers/blood , Cardiac-Gated Imaging Techniques , Cardiotoxicity , Female , Humans , Middle Aged , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Risk Factors , Time Factors , Treatment Outcome , Troponin I/blood , Ventricular Dysfunction, Left/chemically induced , Ventricular Dysfunction, Left/physiopathology
14.
Ann Nucl Med ; 22(5): 437-45, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18600424

ABSTRACT

OBJECTIVE: To develop a method of producing lung ventilation and perfusion (V/Q) planar images using forward projection of reconstructed single-photon emission computed tomography (SPECT) images through approximate attenuation (micro) maps generated from the lung emission scans alone, as transmission-based micro maps may not be routinely available. METHODS: Synthetic micro maps are derived from (99m)Tc photopeak and "scatter" windows for the attenuation correction of the SPECT images. The attenuation-corrected SPECT images are forward projected at appropriate angles to give the equivalent of planar images. This method allows high-count planar images, as well as the SPECT images, to be produced from a single SPECT acquisition. In addition, isolated "single lung" views of lateral and medial projections without "shine-through" from the contra-lateral lung, which have not been available previously, can be formed. RESULTS: Comparison of reprojected images produced from CT-derived or synthetic micro maps displayed similar detail and radiopharmaceutical distribution. In a blinded comparison of "true" planar images with those from reprojecting the SPECT data using the synthetic micro maps, no difference in mismatched defect detection was found, and hence it was confirmed that the reprojected planar images could replace true planar images with no loss in planar diagnostic sensitivity. CONCLUSIONS: The reprojected planar images provide high-count, high-quality images, which are comparable with conventional 2D images.


Subject(s)
Lung/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Sodium Pertechnetate Tc 99m , Tomography, Emission-Computed, Single-Photon/methods , Administration, Inhalation , Humans , Radiopharmaceuticals/administration & dosage , Reproducibility of Results , Sensitivity and Specificity , Sodium Pertechnetate Tc 99m/administration & dosage
15.
Sci Rep ; 8(1): 6739, 2018 04 30.
Article in English | MEDLINE | ID: mdl-29712933

ABSTRACT

Electroacupuncture (EA) is a therapeutic modality in which the electrical stimulation is integrated with concepts of acupuncture to treat diseases. This study was designed to evaluate the connection between the electro-acupuncture induced increase in Na99mTcO4 uptake in the stomach wall, and the ionic molecule levels in the extracellular fluid in the acupoints. Wistar rats were treated by 2 or 100 Hz EA at Zusanli (ST 36) and Xiajuxu (ST 39) bilaterally for 60 minutes. The accumulation of Na99mTcO4 in the gastric wall and the free ions, including Ca2+, K+, Na+, and Cl-, in the acupoints were measured every 60 minutes. The radioactivity uptake in the stomach was significantly increased during EA, reaching peak at 180 minutes after the EA. The concentration of extracellular ions was also significantly increased during EA. The Ca2+ level continued to rise until 60 minutes after EA, then started to decrease at 120 minutes post-EA. The results suggest this up-regulatory effect of EA on gastric activity might be triggered by the increase of the extracellular ion levels, this effect lasts longer than stimulating the release of transmembrane Ca2+ flow alone. This might aid in providing a better understanding of the long-lasting effect claimed in acupuncture treatment.


Subject(s)
Acupuncture Points , Electroacupuncture/methods , Sodium Pertechnetate Tc 99m/administration & dosage , Stomach/physiopathology , Acupuncture Therapy , Animals , Calcium/metabolism , Extracellular Fluid/radiation effects , Humans , Male , Rats , Rats, Wistar , Stomach/radiation effects
16.
J Feline Med Surg ; 20(4): 370-377, 2018 04.
Article in English | MEDLINE | ID: mdl-28689464

ABSTRACT

Objectives The outcome of radioiodine therapy in hyperthyroid cats is suspected to be influenced by multiple factors. The degree of activity of the thyroid gland, represented by uptake of sodium pertechnetate or tracer activities of radioiodine by the thyroid gland on thyroid scintigraphy, has been suggested in the literature as one of those. Thyroid gland pertechnetate uptake can be represented by (semi-)quantitative factors such as the thyroid to salivary gland (T/S) ratio, the thyroid to background (T/B) ratio and the percentage technetium uptake by the thyroid glands (%TcU). The aim of this study was to investigate a possible relationship between these thyroid scan parameters and radioiodine therapy outcome. Methods Sodium pertechnetate thyroid scans of 75 hyperthyroid cats were retrospectively evaluated and statistical analysis was performed with and without correction for injected radioiodine activity. Three different background regions of interest (ROIs) were used to calculate the T/B ratio and %TcU: 'neck', 'circle' and 'copy ROI'. Results Higher T/S ratios were found to be significantly related to a persistent hyperthyroid outcome in both analyses. For the T/S ratio, a threshold value of 5.4 was determined, with a sensitivity of 73% and a specificity of 59%. An increased risk for persistent hyperthyroidism compared with a final euthyroid outcome with an increased T/Bcircle ratio was only found to be significant without correction for the activity of radioiodine administered. For the %TcU no statistical significance was reached. Regarding a low total thyroxine outcome, no significant relationships with any of the investigated parameters were found. Conclusions and relevance The findings of this study suggest that semi-quantification of thyroid gland uptake is best performed using the T/S ratio. A T/S ratio ⩾5.4 is a possible indicator for an increased risk of persistent hyperthyroidism.


Subject(s)
Cat Diseases/diagnostic imaging , Hyperthyroidism/veterinary , Iodine Radioisotopes/administration & dosage , Radionuclide Imaging/veterinary , Animals , Cats , Female , Hyperthyroidism/diagnostic imaging , Male , Neck , Radionuclide Imaging/methods , Retrospective Studies , Sensitivity and Specificity , Sodium Pertechnetate Tc 99m/administration & dosage , Thyroid Gland/diagnostic imaging
17.
Life Sci ; 212: 233-240, 2018 Nov 01.
Article in English | MEDLINE | ID: mdl-30304691

ABSTRACT

AIMS: The in vivo targeted diagnostic applications of biosynthetic Cerium oxide nanoparticles (CeO2-NPs), prepared by applying chitosan as a stabilizer, was explored by evaluating the cytotoxicity through MTT assay on WEHI 164 cell line, the Hemolytic activity of CeO2-NPs and biodistribution in rats. MAIN METHODS: The CeO2-NPs were characterized through the use of TGA/DTG, PXRD, FESEM, FTIR, and UV-Vis spectroscopy. The biodistribution of CeO2-NPs were determined by directly labeled nanoparticles with Technetium-99 m (99mTc) radioisotope (99mTc-CeO2-NPs). The labeling efficiency and stability of 99mTc-CeO2-NPs were also measured with Instant Thin Layer Chromatography (ITLC) method. The saturation study was investigated by 1 mCi of 99mTc-CeO2-NPs using different concentrations of WEHI 164 cells after 4 h of incubation. In vivo biodistribution study was performed by intravenous injection of 600 µCi/200 µL 99mTc-CeO2-NPs through rat's tail. KEY FINDINGS: CeO2-NPs seemed to have a low cytotoxic effect on WEHI 164 cell line and did not result in hemolysis. The biodistribution of CeO2-NPs has shown that a huge amount of 99mTc-CeO2-NPs was amassed in the living human organs, including liver, lung, spleen, stomach, and thyroid which shows the in vivo stability of the labeled conjugate. Herein, we have developed a facile, economical, and greener synthetic procedure applying Chitosan template. This green approach is comparable to conventional methods that utilize hazardous materials which are would be a suitable alternative to circumvent synthetic issues related to these materials. SIGNIFICANCE: The bio-applications of nano-sized CeO2-NPs were explored to find new horizon to use nanotechnology as the diagnostic tool.


Subject(s)
Cerium/chemistry , Fibrosarcoma/drug therapy , Metal Nanoparticles/administration & dosage , Radiopharmaceuticals/pharmacokinetics , Sodium Pertechnetate Tc 99m/pharmacokinetics , Animals , Cell Proliferation/drug effects , Fibrosarcoma/metabolism , Fibrosarcoma/pathology , Hemolysis/drug effects , Humans , Male , Metal Nanoparticles/chemistry , Mice , Radiopharmaceuticals/administration & dosage , Radiopharmaceuticals/chemistry , Rats, Wistar , Sodium Pertechnetate Tc 99m/administration & dosage , Sodium Pertechnetate Tc 99m/chemistry , Tissue Distribution , Tumor Cells, Cultured
18.
Hum Gene Ther ; 18(4): 312-22, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17408358

ABSTRACT

This study was done to aid in the design of a phase I gene therapy trial in patients with prostate cancer. We determined the dosimetric characteristics of our reporter gene system when coupled with intravenous administration of radioactive sodium pertechnetate (Na(99m) TcO(4)) and determined the feasibility of using human sodium iodide symporter (hNIS) as a reporter gene to study the dynamics of adenoviral transgene expression in a large animal tumor. A replication-competent Ad5-yCD/mutTK(SR39) rep-hNIS adenovirus was injected into the prostate gland of dogs for dosimetry purposes, and into a canine soft tissue sarcoma (STS) for imaging purposes. After resection of the prostate, the amount of (99m)TcO(4)() sequestered in the prostate was determined, the radiation dose absorbed by the prostate and nontarget critical organs was calculated, and hNIS reporter gene expression was imaged in the STS by single-photon emission computed tomography (SPECT). On the basis of the findings from 25 dogs, the amount of (99m)TcO (4)() sequestered in the prostate ranged from 13 to 276 muCi. Using the highest value observed, absorbed radiation dose to critical organs was calculated and found to be below U.S. Food and Drug Administration limits for diagnostic imaging. Also, (99m)TcO (4)() uptake was readily detected by SPECT and found to persist in vivo for at least 4 days. On the basis of our dosimetry calculations, up to five imaging procedures can be safely performed in humans after intraprostatic injection of the Ad5-yCD/mutTK(SR39)rep-hNIS adenovirus and the hNIS reporter gene system can be used to study the dynamics of adenoviral gene therapy vectors in large animal tumors.


Subject(s)
Clinical Trials, Phase I as Topic/standards , Genes, Reporter , Prostatic Neoplasms/therapy , Radiographic Image Interpretation, Computer-Assisted , Sodium Pertechnetate Tc 99m/pharmacokinetics , Symporters/genetics , Animals , Dogs , Genetic Therapy , Genetic Vectors , Humans , Male , Research Design , Sodium Pertechnetate Tc 99m/administration & dosage , Sodium Pertechnetate Tc 99m/analysis , Tissue Distribution
19.
J Aerosol Med ; 20(3): 331-41, 2007.
Article in English | MEDLINE | ID: mdl-17894539

ABSTRACT

In this study, the influence of lung function on lung deposition of a radioactively labeled Formotoerol HFA MDI (Forair) was investigated. Eighteen subjects were measured: 6 healthy subjects (FEV(1) = 107% pred), 6 patients with Asthma (FEV(1) = 72% pred), and 6 patients with COPD (FEV(1) = 40% pred). The lung deposition of the radioactive-labeled drug was measured with a gamma camera. The lung deposition relative to the emitted dose was 31% for healthy subjects, 34% for asthmatics, and 35% for COPD patients. These data suggest a comparable lung deposition in the different populations. There was no significant correlation between lung function (FEV(1)) and lung deposition. The extrathoracic deposition was around 50%. The finding were that lung deposition of the inhaled Formoterol did not depend on lung function and the relative high values of lung deposition can be explained by the small particle size (0.8 microm) of the HFA-Formoterol-Formulation and the slow inhalation (30 L/min flow) used in this study. It can be concluded, that with this modern HFA drug formulation, the deposition is high, even in obstructed lungs.


Subject(s)
Asthma/diagnostic imaging , Bronchodilator Agents/administration & dosage , Ethanolamines/administration & dosage , Lung/diagnostic imaging , Metered Dose Inhalers , Pulmonary Disease, Chronic Obstructive/diagnostic imaging , Radiopharmaceuticals/administration & dosage , Sodium Pertechnetate Tc 99m/administration & dosage , Administration, Inhalation , Adult , Aerosols , Aged , Asthma/metabolism , Asthma/physiopathology , Bronchodilator Agents/blood , Bronchodilator Agents/pharmacokinetics , Ethanolamines/blood , Ethanolamines/pharmacokinetics , Female , Forced Expiratory Volume , Formoterol Fumarate , Humans , Lung/metabolism , Lung/physiopathology , Male , Middle Aged , Particle Size , Pulmonary Disease, Chronic Obstructive/metabolism , Pulmonary Disease, Chronic Obstructive/physiopathology , Radionuclide Imaging
20.
Am J Chin Med ; 35(6): 977-86, 2007.
Article in English | MEDLINE | ID: mdl-18186584

ABSTRACT

In clinical acupuncture, when acupuncture points are stimulated, several types of reflex responses can be evoked. Consequently, different categories of physiological responses are induced, which include changes in the activities of internal organs and tissues. The acupuncture point Sanyinjiao (SP6) has been used successfully to treat different human gastrointestinal conditions. The aim of this work was to investigate the effects of end-organ response induced by acupuncture point SP6 on the bioavailability of the radiopharmaceutical sodium pertechnetate (Na99mTcO4) in Wistar rats. Healthy rats were allocated into 2 groups, control-CG and treated-TG. TG was bilaterally stimulated at acupuncture point SP6 with stainless steel needles. Ocular plexus administration of Na99mTcO4 (3.7MBq) was carried out 10 min after every needle insertion in all animals. Ten minutes later, the animals were killed, the organs were isolated, the radioactivity was determined in a well gamma counter, and the percentage of injected dose per gram of tissue (%ID/g) was determined for each organ. The %ID/g was significantly altered (p < 0.05) in the small intestine of TG (0.56 +/- 0.09) when compared to CG (0.82 +/- 0.18). These results may suggest that this stimulation might induce physiological responses capable of altering the bioavailability of the radiopharmaceutical sodium pertechnetate. These findings aid in providing a better understanding of acupuncture and its effects on various organs and tissues.


Subject(s)
Acupuncture Points , Acupuncture/methods , Radiopharmaceuticals/pharmacokinetics , Sodium Pertechnetate Tc 99m/pharmacokinetics , Animals , Biological Availability , Injections, Intraperitoneal , Intestine, Small/metabolism , Liver/metabolism , Male , Pancreas/metabolism , Radiopharmaceuticals/administration & dosage , Rats , Rats, Wistar , Sodium Pertechnetate Tc 99m/administration & dosage , Spleen/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL